The biology of tryptophan depletion and mood disorders

Israel Journal of Psychiatry and Related Sciences

Volumn 47, Issue 1, 2010, Pages 46-55

  Toker, Lilach ^a   Amar, Shirly ^a   Bersudsky, Yuly ^a   Benjamin, Jonathan ^a   Klein, Ehud ^b   Agam, Galila ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953215676     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. McAllister-Williams RH, Massey AE, Rugg MD. Effects of tryptophan depletion on brain potential correlates of episodic memory retrieval. Psychopharmacology 2002;160:434-442.
2. Perez-Cruet J, Chase TN, Murphy DL. Dietary regulation of brain tryptophan metabolism by plasma ratio of free tryptophan and neutral amino acids in humans. Nature 1974;248:693-695.
3. Fernstrom JD, Hirsch MJ, Faller DV. Tryptophan concentrations in rat brain. Failure to correlate with free serum tryptophan or its ratio to the sum of other serum neutral amino acids. Biochem J 1976;160:589-595.
4. Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003;66:1673-1680.
5. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology. Eighth Edition. New York: Oxford University, 2003.
6. Smith CUM. Elements of molecular neurobiology. Second Edition. New York: Wiley, 1996.
7. Reilly JG, McTavish SF, Young AH. Rapid depletion of plasma tryptophan: A review of studies and experimental methodology. J Psychopharmacol 1997;11:381-392.
8. Lieben CK, Blokland A, Westerink B, Deutz NE. Acute tryptophan and serotonin depletion using an optimized tryptophan-free protein-carbohydrate mixture in the adult rat. Neurochem Int 2004;44:9-16.
9. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411-418.
10. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN. Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 1994;51:687-697.
11. Young SN, Smith SE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 1985;87:173-177.
12. Young SN, Tourjman SV, Teff KL, Pihl RO, Anderson GH. The effect of lowering plasma tryptophan on food selection in normal males. Pharmacol Biochem Behav 1988;31:149-152.
13. LL, Anderson GM, Pelton GH, Gudin JA, Kirwin PD, Price LH, et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998;19:26-35.
14. Young SN, Leyton M, Benkelfat C. Pet studies of serotonin synthesis in the human brain. Adv Exp Med Biol 1999;467:11-18.
15. Miczek KA, Altman JL, Appel JB, Boggan WO. Parachlorophenylalanine, serotonin and killing behavior. Pharmacol Biochem Behav 1975;3:355-361.
16. Herges S, Taylor DA. Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat. Eur J Pharmacol 1999;374:329-340. (Pubitemid 29313445)
17. Sanders-Bush E, Bushing JA, Sulser F. p-Chloroamphetamine-inhibition of cerebral tryptophan hydroxylase. Biochem Pharmacol 1972;21:1501-1510.
18. Harvey JA, McMaster SE. Fenfluramine: evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin. Psychopharmacol Commun 1975;1:217-228.
19. Fuller RW. Effects of p-chloroamphetamine on brain serotonin neurons. Neurochem Res 1992;17:449-456.
20. Andrade TG, Graeff FG. Effect of electrolytic and neurotoxic lesions of the median raphe nucleus on anxiety and stress. Pharmacol Biochem Behav 2001;70:1-14.
21. Richter-Levin G, Segal M. The effects of serotonin depletion and raphe grafts on hippocampal electrophysiology and behavior. J Neurosci 1991;11:1585-1596.
22. Zimmermann RC, McDougle CJ, Schumacher M, Olcese J, Mason JW, Heninger GR, et al. Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans. J Clin Endocrinol Metab 1993;76:1160-1164.
23. Oxenkrug GF. Tryptophan-kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: "The serotonin hypothesis" revisited 40 years later. Isr J Psychiatry and Relat Sci 2010; 47: 56-63.
24. Harper AE, Benevenga NJ, Wohlhueter RM. Effects of ingestion of disproportionate amounts of amino acids. Physiol Rev 1970;50:428-558.
25. Weltzin TE, Fernstrom MH, Fernstrom JD, Neuberger SK, Kaye WH. Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. Am J Psychiatry 1995;152:1668-1671.
26. Lee YS, Naito H, Kametaka M. The effect of force feeding a tryptophan-deficient diet on arterio-venous difference of plasma amino acids across skeletal muscle of rats. J Nutr 1977;109:119-128.
27. Spector H, Adamstone FB. Tryptophan deficiency in the rat induced by forced feeding of an acid hydrolyzed casein diet. J Nutr 1950;40:213-229.
28. Albanese AA, Emmet Holt E, Kajdi CN, Frankston JE. Observation on tryptophane deficiency in rats chemical and morphological changes in the blood. J Biol Chem 1943;148:299-309.
29. Sidransky H. Tryptophan: Biochemical and health implications, chapter 2: Findings in deficiency states, pp. 8-18. Boca Raton, Florida: CRC, 2001.
30. Vrensen GF, van Marle J, Jonges R, Voorhout W, Breipohl W, Wegener AR. Tryptophan deficiency arrests chromatin breakdown in secondary lens fibers of rats. Exp Eye Res 2004;78:661-672.
31. Bortolato M, Frau R, Orru M, Collu M, Mereu G, Carta M, et al. Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats. Psychopharmacology (Berl) 2008;198:191-200.
32. Cahir M, Ardis T, Reynolds GP, Cooper SJ. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl) 2007;190:497-506.
33. Jensen JB, Jessop DS, Harbuz MS, Mork A, Sanchez C, Mikkelsen JD. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol 1999;11:465-471.
34. Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 2004;55:1171-1178.
35. Shishkina GT, Kalinina TS, Dygalo NN. Up-regulation of tryptophan hydroxylase-2 mRNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effect. Neuroscience 2007;150:404-412.
36. Prisco S, Esposito E. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br J Pharmacol 1995;116:1923-1931.
37. Young SN, Smith SE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl) 1985;87:173-177.
38. Moore P, Landolt HP, Seifritz E, Clark C, Bhatti T, Kelsoe J, et al. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 2000;23:601-622.
39. Knott VJ, Howson AL, Perugini M, Ravindran AV, Young SN. The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects. Biol Psychiatry 1999;46:229-238.
40. Ellenbogen MA, Young SN, Dean P, Palmour RM, Benkelfat C. Mood response to acute tryptophan depletion in healthy volunteers: Sex differences and temporal stability. Neuropsychopharmacology 1996;15:465-474.
41. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997;94:5308-5313.
42. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: Implications for affective regulation. Biol Psychiatry 1998;44:839-850.
43. Epperson CN, Amin Z, Naftolin F, Cappiello A, Czarkowski KA, Stiklus S, et al. The resistance to depressive relapse in menopausal women undergoing tryptophan depletion: Preliminary findings. J Psychopharmacol 2007;21:414-420.
44. Jans LA, Lieben CK, Blokland A. Influence of sex and estrous cycle on the effects of acute tryptophan depletion induced by a gelatin-based mixture in adult Wistar rats. Neuroscience 2007;147:304-317.
45. Quintin P, Benkelfat C, Launay JM, Arnulf I, Pointereau-Bellenger A, Barbault S, et al. Clinical and neurochemical effect of acute tryptophan depletion in unaffected relatives of patients with bipolar affective disorder. Biol Psychiatry 2001;50:184-190.
46. Klaassen T, Riedel WJ, van Someren A, Deutz NE, Honig A, van Praag HM. Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry 1999;46:489-497.
47. Ellenbogen MA, Young SN, Dean P, Palmour RM, Benkelfat C. Acute tryptophan depletion in healthy young women with a family history of major affective disorder. Psychol Med 1999;29:35-46.
48. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, et al. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 1994;51:865-874.
49. Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA. Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 2005;55:242-251.
50. Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerdere P, Caccia S, et al. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 2002;26:311-324.
51. Leysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janssen PA. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: Ritanserin and setoperone. Psychopharmacology 1986;88:434-444.
52. Pranzatelli MR. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. Biochem Pharmacol 1991;42:1099-1105.
53. Pranzatelli MR, Murthy JN, Tailor PT. Novel regulation of 5-HT1C receptors: Down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists. Eur J Pharmacol 1993;244:1-5.
54. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997;387:303-308.
55. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C. Altered editing of serotonin 2C receptor premRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002;34:349-356.
56. Gurevich I, Englander MT, Adlersberg M, Siegal NB, Schmauss C. Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 2002;22:10529-10532.
57. Ni YG, Miledi R. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 1997;94:2036-2040.
58. Smith KA, Fairburn CG, Cowen PJ. Relapse of depression after rapid depletion of tryptophan. Lancet 1997;349:915-919.
59. Moreno FA, Gelenberg AJ, Heninger GR, Potter RL, McKnight KM, Allen J, et al. Tryptophan depletion and depressive vulnerability. Biol Psychiatry 1999;46:498-505.
60. Leyton M, Ghadirian AM, Young SN, Palmour RM, Blier P, Helmers KF, et al. Depressive relapse following acute tryptophan depletion in patients with major depressive disorder. J Psychopharmacol 2000;14:284-287.
61. Neumeister A, Praschak-Rieder N, Hesselmann B, Vitouch O, Rauh M, Barocka A, et al. Effects of tryptophan depletion in fully remitted patients with seasonal affective disorder during summer. Psychol Med 1998;28:257-264.
62. Leyton M, Young SN, Benkelfat C. Relapse of depression after rapid depletion of tryptophan. Lancet 1997;349:1840-1841.
63. Lam RW, Bowering TA, Tam EM, Grewal A, Yatham LN, Shiah IS, et al. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in natural summer remission. Psychol Med 2000;30:79-87.
64. Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 1997;54:364-374.
65. Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry 1999;174:525-529.
66. Praschak-Rieder N, Hussey D, Wilson AA, Carella A, Lee M, Dunn E, et al. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: An [(18)F] MPPF positron emission tomography study. Biol Psychiatry 2004;56:587-591.
67. Cornelisse LN, Van der Harst 67. JE, Lodder JC, Baarendse PJ, Timmerman AJ, Mansvelder HD, et al. Reduced 5-HT1Aand GABAB receptor function in dorsal raphe neurons upon chronic fluoxetine treatment of socially stressed rats. J Neurophysiol 2007;98:196-204.
68. McGehee DS. GIRK channels as a target for SSRIs. Focus on "reduced 5-HT1A- and GABAB receptor function in dorsal raphe neurons upon chronic fluoxetine treatment of socially stressed rats." J Neurophysiol 2007;98:1-2.
69. Rossi DV, Burke TF, McCasland M, Hensler JG. Serotonin- 1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline. J Neurochem 2008;105:1091-1099.
70. Delgado PL, Price LH, Miller HL, Salomon RM, Licinio J, Krystal JH, et al. Rapid serotonin depletion as a provocative challenge test for patients with major depression: Relevance to antidepressant action and the neurobiology of depression. Psychopharmacol Bull 1991;27:321-330.
71. Delgado PL, Miller HL, Salomon RM, Licinio J, Krystal JH, Moreno FA, et al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999;46:212-220.
72. Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry 1996;53:41-44.
73. Neumeister A, Praschak-Rieder N, Besselmann B, Rao ML, Gluck J, Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry 1997;54:133-138.
74. Hughes JH, Dunne F, Young AH. Effects of acute tryptophan depletion on mood and suicidal ideation in bipolar patients symptomatically stable on lithium. Br J Psychiatry 2000;177:447-451.
75. Neumeister A, Praschak-Rieder N, Hesselmann B, Vitouch O, Rauh M, Barocka A, et al. Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation. Arch Gen Psychiatry 1998;55:167-172.
76. Benkelfat C, Seletti B, Palmour RM, Hillel J, Ellenbogen M, Young SN. Tryptophan depletion in stable lithium-treated patients with bipolar disorder in remission. Arch Gen Psychiatry 1995;52:154-156.
77. Cassidy F, Murry E, Carroll BJ. Tryptophan depletion in recently manic patients treated with lithium. Biol Psychiatry 1998;43:230-232.
78. Johnson L, El-Khoury A, Aberg-Wistedt A, Stain-Malmgren R, Mathe AA. Tryptophan depletion in lithium-stabilized patients with affective disorder. Int J Neuropsychopharmacol 2001;4:329-336.
79. Cappiello A, Sernyak MJ, Malison RT, McDougle CJ, Heninger GR, Price LH. Effects of acute tryptophan depletion in lithium-remitted manic patients: A pilot study. Biol Psychiatry 1997;42:1076-1078.
80. Hughes JH, Gallagher P, Young AH. Effects of acute tryptophan depletion on cognitive function in euthymic bipolar patients. Eur Neuropsychopharmacol 2002;12:123-128.
81. Shopsin B, Friedman E, Gershon S. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiatry 1976;33:311-319.
82. Applebaum J, Bersudsky Y, Klein E. Rapid tryptophan depletion as a treatment for acute mania: A double-blind, pilot-controlled study. Bipolar Disord 2007 ;9:884-887.
83. Minov C, Baghai TC, Schule C, Zwanzger P, Schwarz MJ, Zill P, et al. Serotonin-2A-receptor and -transporter polymorphisms: Lack of association in patients with major depression. Neurosci Lett 2001;303:119-122.
84. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000;57:729-738.
85. Lotrich FE, Pollock BG, Ferrell RE. Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors. Am J Pharmacogenomics 2001;1:153-164.
86. Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, et al. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 2004;61:177-183.
87. Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 1998;44:179-192.
88. Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J, et al. Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 2002;7:213-216.
89. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M, et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 2002;59:613-620.
90. Neumeister A, Hu XZ, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O, et al. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 2006;63:978-986.
91. Booij L, Van der Does AJ, Haffmans PM, Riedel WJ, Fekkes D, Blom MJ. The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. J Psychopharmacol 2005;19:267-275.
92. Merens W, van der Does W. Low-dose tryptophan depletion. Biol Psychiatry 2007;62:542-543; author reply 543-544.
93. Young SN. Rapid tryptophan depletion as a treatment for acute mania: Safety and mechanism of the therapeutic effect. Bipolar Disord 2008;10:850-851.
94. Zepf FD, Wöckel L, Herpertz-Dahlmann B, Poustka F, Freitag CM. Tryptophan depletion in bipolar mania: Reduction of metabolic imbalance by administration according to body weight? Bipolar Disord 2009;11:557-558.